Phio Pharmaceuticals Corp. - Common Stock (NQ:PHIO)

1.245 -0.045 (-3.49%)

Streaming Delayed Price Updated: 2:53 PM EST, Feb 12, 2026 Add to My Watchlist

Price and Volume

Volume	3,044,068
Open	1.280
Bid (Size)	1.240 (2,800)
Ask (Size)	1.250 (1,800)
Prev. Close	1.290
Today's Range	1.200 - 1.340
52wk Range	0.8127 - 4.190
Shares Outstanding	5,726,750
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

On Wednesday, there are stocks with unusual volume. Let's take a look. ↗

February 11, 2026

Via Chartmill

Top stock movements in today's session. ↗

February 10, 2026

Via Chartmill

Performance

YTD	+14.2%	+14.2%
1 Month	+4.6%	+4.6%
3 Month	-21.2%	-21.2%
6 Month	-43.2%	-43.2%
1 Year	-30.1%	-30.1%

More News

These stocks are making the most noise in today's session. ↗

February 10, 2026

Via Chartmill

Here are the top movers in Tuesday's session. ↗

February 10, 2026

Via Chartmill

These stocks are gapping in today's session ↗

February 10, 2026

Via Chartmill

Top movers in Tuesday's pre-market session ↗

February 10, 2026

Via Chartmill

Phio Announces Safety Monitoring Committee's (SMC) Positive Wrap-up on Lead Clinical Candidate PH-762 in Skin Cancer Trial

February 10, 2026

Via Newsfile

Phio Pharmaceuticals Announces Participation in Third Annual DealFlow Discovery Conference

January 26, 2026

Via Newsfile

Phio Pharmaceuticals Announces Key Tumor Response Data from all Cohorts in Intratumoral PH-762 Dose Escalation Cutaneous Carcinoma Trial

January 20, 2026

Via Newsfile

Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference January 21-22, 2026

January 15, 2026

Via Newsfile

Phio Pharmaceuticals Announces Significant Step Forward in its Drug Development Program for PH-762

December 23, 2025

Via Newsfile

Phio Pharmaceuticals Announces Completion of Enrollment in Phase 1b Clinical Trial of INTASYL siRNA Lead Compound PH-762

November 25, 2025

Via Newsfile

Phio Pharmaceuticals Announces Upcoming Podium Presentation at the Advanced Therapies USA 2025 Congress

November 17, 2025

Via Newsfile

Phio Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update

November 13, 2025

Via Newsfile

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 13, 2025

Via Benzinga

Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally

November 07, 2025

Via MarketMinute

Phio Pharmaceuticals to Present Recent Clinical Results from Skin Cancer Trial with siRNA based INTASYL PH-762

November 07, 2025

Via Newsfile

Phio Pharmaceuticals Announces INTASYL PH-762 is Named Immunomodulatory Solution of the Year in the BioTech Breakthrough Award Program

November 07, 2025

Via Newsfile

Aprea Therapeutics (Nasdaq: APRE) Transforms Cutting-Edge Science into Next-Generation Cancer Therapies – More Stocks Inside

November 03, 2025

Via AB Newswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 03, 2025

Via Benzinga

These stocks are the most active in today's session ↗

November 03, 2025

Via Chartmill

Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $13.4 Million Gross Proceeds

November 03, 2025

Via Newsfile

Why Is Phio Pharmaceuticals Stock Soaring Today? ↗

November 03, 2025

Via Benzinga

Top movers analysis in the middle of the day on 2025-11-03: top gainers and losers in today's session. ↗

November 03, 2025

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 03, 2025

Via Benzinga

Frequently Asked Questions

Is Phio Pharmaceuticals Corp. - Common Stock publicly traded?

Yes, Phio Pharmaceuticals Corp. - Common Stock is publicly traded.

What exchange does Phio Pharmaceuticals Corp. - Common Stock trade on?

Phio Pharmaceuticals Corp. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Phio Pharmaceuticals Corp. - Common Stock?

The ticker symbol for Phio Pharmaceuticals Corp. - Common Stock is PHIO on the Nasdaq Stock Market

What is the current price of Phio Pharmaceuticals Corp. - Common Stock?

The current price of Phio Pharmaceuticals Corp. - Common Stock is 1.245

When was Phio Pharmaceuticals Corp. - Common Stock last traded?

The last trade of Phio Pharmaceuticals Corp. - Common Stock was at 02/12/26 02:53 PM ET

What is the market capitalization of Phio Pharmaceuticals Corp. - Common Stock?

The market capitalization of Phio Pharmaceuticals Corp. - Common Stock is 7.13M

How many shares of Phio Pharmaceuticals Corp. - Common Stock are outstanding?

Phio Pharmaceuticals Corp. - Common Stock has 7M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.